Phil Burcham is an associate professor in the School of Medicine and Pharmacology at the University of Western Australia. Burcham has over three decades of experience in pharmacology and toxicology, completing postdoctoral work in molecular toxicology at Vanderbilt University in the USA. His research interests mainly focus on acrolein and he is currently looking at identifying novel drugs that block acrolein toxicity. Burcham serves on the editorial boards of Toxicological Sciences and Biochemical Pharmacology, and was a foundation member of the Toxicology subsection of Faculty 1000 (Biology).